HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Involvement of endocannabinoid neurotransmission in the bed nucleus of stria terminalis in cardiovascular responses to acute restraint stress in rats.

AbstractBACKGROUND AND PURPOSE:
Endocannabinoid signalling has been reported as an important neurochemical mechanism involved in responses to stress. Previous studies provided evidence of endocannabinoid release in the bed nucleus of the stria terminalis (BNST) during aversive stimuli. Nevertheless, a possible involvement of this neurochemical mechanism in stress responses has never been evaluated. Therefore, in the present study we investigated the involvement of BNST endocannabinoid neurotransmission, acting via local CB1 receptors, in the cardiovascular responses to acute restraint stress in rats.
EXPERIMENTAL APPROACH:
The selective CB1 receptor antagonist AM251 (1, 30 and 100 pmol 100 nL(-1) ) and/or the fatty acid amide hydrolase (FAAH) enzyme inhibitor URB597 (30 pmol 100 nL(-1) ) or the monoacylglycerol lipase (MAGL) enzyme inhibitor JZL184 (30 pmol 100 nL(-1) ) was microinjected into the BNST before the acute restraint stress.
KEY RESULTS:
Microinjection of AM251 into the BNST enhanced the tachycardia caused by restraint stress, without affecting the increase in arterial pressure and the sympathetic-mediated cutaneous vasoconstrictor response. Conversely, the increased endogenous levels of AEA in the BNST evoked by local treatment with the FAAH enzyme inhibitor URB597 decreased restraint-evoked tachycardia. Inhibition of the hydrolysis of 2-arachidonoylglycerol (2-AG) in the BNST by local microinjection of the MAGL enzyme inhibitor JZL184 also decreased the HR response. These effects of URB597 and JZL184 were abolished by BNST pretreatment with AM251.
CONCLUSIONS AND IMPLICATIONS:
These findings indicate an involvement of BNST endocannabinoid neurotransmission, acting via CB1 receptors, in cardiovascular adjustments during emotional stress, which may be mediated by the local release of either AEA or 2-AG.
AuthorsLucas Gomes-de-Souza, Leandro A Oliveira, Ricardo Benini, Patrícia Rodella, Willian Costa-Ferreira, Carlos C Crestani
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 173 Issue 19 Pg. 2833-44 (10 2016) ISSN: 1476-5381 [Electronic] England
PMID27441413 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2016 The British Pharmacological Society.
Chemical References
  • Benzamides
  • Benzodioxoles
  • Carbamates
  • Endocannabinoids
  • JZL 184
  • Piperidines
  • Pyrazoles
  • cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester
  • AM 251
Topics
  • Acute Disease
  • Animals
  • Benzamides (pharmacology)
  • Benzodioxoles (pharmacology)
  • Carbamates (pharmacology)
  • Cardiovascular System (drug effects, physiopathology)
  • Dose-Response Relationship, Drug
  • Endocannabinoids (metabolism)
  • Male
  • Piperidines (pharmacology)
  • Pyrazoles (pharmacology)
  • Rats
  • Rats, Wistar
  • Restraint, Physical
  • Septal Nuclei (drug effects, metabolism)
  • Stress, Psychological
  • Structure-Activity Relationship
  • Synaptic Transmission (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: